12:00 AM
 | 
Jan 10, 2011
 |  BC Week In Review  |  Financial News  |  Completed Offerings

Adventrx completes direct public offering

Adventrx Pharmaceuticals Inc. (NYSE-A:ANX), San Diego, Calif.
Business: Cancer, Infectious
Date completed: 1/7/11
Type: Direct public offering
Raised: $22.5...

Read the full 71 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >